Report #2858277

Received Sep 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 95 yrs
State: MI
Recovered: Unknown
Vaccinated: Aug 13, 2025
Onset: Aug 13, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	2	957D4	—

Symptoms (1)

Extra dose administered

Symptom narrative

pharmacist gave him a 2nd shot; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 95-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 957D4, expiry date 27-NOV-2026) for prophylaxis. Concomitant products included RSV VACCINE PROT. SUBUNIT PREF3 (AREXVY). On 13-AUG-2025, the patient received the 2nd dose of Arexvy. On 13-AUG-2025, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: pharmacist gave him a 2nd shot). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date :14-AUG-2025 and 15-AUG-2025 Pharmacist reported that a patient did not realize that he already had an RSV Arexvy 15th May 2025 and the day before reporting, the pharmacist gave him a 2nd shot, which led to extra dose administered. No further details were provided. The reporter was consented to follow up.

Other medications

AREXVY